NYSE · Medical - Instruments & Supplies

Stevanato Group S.p.A. (STVN) Stock

$19.40 +0.99% NYSE: STVN Healthcare

Valuation

MetricValue
Price$19.40
Market Cap$5.30B
P/E Ratio37.38
P/B Ratio3.16
P/S Ratio4.01
EPS (TTM)$0.49
52-Week High$27.99
52-Week Low$12.89
Dividend Yield0.30%

Financials & Margins

MetricValue
ROE8.94%
ROA5.13%
ROCE9.63%
Gross Margin16.07%
Operating Margin16.07%
Net Margin10.99%
Debt/Equity0.29
Current Ratio1.74

Annual Financials (USD)

Metric20212022202320242025
Revenue$844.0M$984.0M$1.1B$1.1B$1.1B
Operating Profit$162.0M$192.0M$201.0M$161.0M$183.0M
Net Profit$134.0M$143.0M$146.0M$118.0M$134.0M
EPS$0.53$0.53$0.55$0.43$0.49
Op Margin19.2%19.6%18.5%14.6%16.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.4B$1.7B$2.1B$2.3B$2.5B
Total Liabilities$577.0M$664.0M$939.0M$924.0M$1.1B
Cash$411.0M$229.0M$70.0M$98.0M$131.0M
Borrowings$244.0M$218.0M$397.0M$429.0M$471.0M

Latest News

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026 Business Wire · Jul 21, 2026 Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? Zacks · Jul 7, 2026 TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN) Insider Monkey · Jul 1, 2026 Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last? Zacks · Jun 23, 2026 TD Cowen Initiates Stevanato at Buy With $25 Price Target MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$133.0M$103.0M$105.0M$156.0M$275.0M
Investing Cash Flow$-210.0M$-486.0M$-863.0M$-624.0M$-515.0M
Financing Cash Flow$6.0M$0$0$0$-6.0M
Net Cash Flow$295.0M$-182.0M$-159.0M$29.0M$44.0M
Free Cash Flow$20.0M$-140.0M$-337.0M$-158.0M$21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-9.35
EV / EBITDA19.35
FCF Yield-0.52%
Quick Ratio1.08
Interest Coverage20.69
Return 1Y-8.15%
Return 3Y-37.13%
Return 5Y-23.26%

Ownership

Insiders Held1.65%
Institutions Held97.41%
Institutions Float Held99.04%
Institutional HolderSharesReport Date
Conestoga Capital Advisors, LLC8,491,7512026-03-31
Neuberger Berman Group, LLC4,475,4922026-03-31
Times Square Capital Management, LLC3,489,7162026-03-31
T. Rowe Price Investment Management, Inc.3,224,9082026-03-31
BAMCO Inc.2,500,4382026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATRAptarGroup, Inc. $120.38 -1.17% 21.41 $7.68B 1.60%
AVTRAvantor, Inc. $15.67 +1.82% -18.29 $10.60B 0.00%
AXSMAxsome Therapeutics, Inc. $168.35 -1.02% -49.17 $8.66B 0.00%
BLCOBausch + Lomb Corporation $17.30 +0.87% -35.85 $6.18B 0.00%
BTSGBrightSpring Health Services, Inc. $63.74 +0.13% 43.36 $12.51B 0.00%

About Stevanato Group S.p.A.

Stevanato Group S.p.A. (STVN) stock trades at $19.40 with a market capitalization of $5.30B. The stock is valued at a price-to-earnings (P/E) ratio of 37.38, price-to-book of 3.16, price-to-sales of 4.01. Over the past 52 weeks the stock has ranged between $12.89 and $27.99, and currently trades 30.7% below its 52-week high. It pays a dividend yielding 0.30%.

On profitability, Stevanato Group S.p.A. generates a return on equity (ROE) of 8.94%, return on capital employed of 9.63%, an operating margin of 16.07%, a net profit margin of 10.99%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides